12-2664961-A-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP2PP3
The NM_000719.7(CACNA1C):c.4369A>T(p.Ile1457Phe) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: not found (cov: 33)
Consequence
CACNA1C
NM_000719.7 missense
NM_000719.7 missense
Scores
7
9
1
Clinical Significance
Conservation
PhyloP100: 4.83
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1C. . Gene score misZ 6.4654 (greater than the threshold 3.09). Trascript score misZ 7.2674 (greater than threshold 3.09). GenCC has associacion of gene with intellectual disability, neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures, Brugada syndrome, long QT syndrome, short QT syndrome, long qt syndrome 8, Timothy syndrome, Brugada syndrome 3.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.778
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.4369A>T | p.Ile1457Phe | missense_variant | 35/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.4369A>T | p.Ile1457Phe | missense_variant | 35/47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.4369A>T | p.Ile1457Phe | missense_variant | 35/47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.4369A>T | p.Ile1457Phe | missense_variant | 35/47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.4603A>T | p.Ile1535Phe | missense_variant | 37/50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.4369A>T | p.Ile1457Phe | missense_variant | 35/48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.4336A>T | p.Ile1446Phe | missense_variant | 34/47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.4534A>T | p.Ile1512Phe | missense_variant | 36/48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.4513A>T | p.Ile1505Phe | missense_variant | 37/49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.4435A>T | p.Ile1479Phe | missense_variant | 35/47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.4369A>T | p.Ile1457Phe | missense_variant | 35/48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.4369A>T | p.Ile1457Phe | missense_variant | 35/48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.4459A>T | p.Ile1487Phe | missense_variant | 35/47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.4459A>T | p.Ile1487Phe | missense_variant | 35/47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.4459A>T | p.Ile1487Phe | missense_variant | 35/47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.4459A>T | p.Ile1487Phe | missense_variant | 35/47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.4453A>T | p.Ile1485Phe | missense_variant | 36/48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.4444A>T | p.Ile1482Phe | missense_variant | 36/48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.4429A>T | p.Ile1477Phe | missense_variant | 36/48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.4369A>T | p.Ile1457Phe | missense_variant | 35/47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.4369A>T | p.Ile1457Phe | missense_variant | 35/47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.4369A>T | p.Ile1457Phe | missense_variant | 35/47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.4420A>T | p.Ile1474Phe | missense_variant | 35/47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.4411A>T | p.Ile1471Phe | missense_variant | 35/47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.4336A>T | p.Ile1446Phe | missense_variant | 34/46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.4336A>T | p.Ile1446Phe | missense_variant | 34/46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.4330A>T | p.Ile1444Phe | missense_variant | 34/46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.4369A>T | p.Ile1457Phe | missense_variant | 35/47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.4369A>T | p.Ile1457Phe | missense_variant | 35/47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.4369A>T | p.Ile1457Phe | missense_variant | 35/47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.4369A>T | p.Ile1457Phe | missense_variant | 35/47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.4369A>T | p.Ile1457Phe | missense_variant | 35/47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.4360A>T | p.Ile1454Phe | missense_variant | 35/47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.4336A>T | p.Ile1446Phe | missense_variant | 34/46 | ENSP00000507309.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | May 27, 2022 | - - |
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2018 | This variant has not been reported in the literature in individuals with CACNA1C-related disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant is not present in population databases (ExAC no frequency). This sequence change replaces isoleucine with phenylalanine at codon 1457 of the CACNA1C protein (p.Ile1457Phe). The isoleucine residue is highly conserved and there is a small physicochemical difference between isoleucine and phenylalanine. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
.;.;.;.;.;.;.;.;.;.;M;.;.;.;.;.;.;.;.;.;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;.
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;.
Sift4G
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Polyphen
0.97, 0.99, 0.99, 0.95, 0.97, 0.91, 0.99, 0.96
.;D;D;D;D;D;P;P;D;D;P;P;P;D;P;.;P;P;.;.;.;D;.
Vest4
MutPred
0.60
.;.;.;.;.;.;.;.;.;.;Gain of catalytic residue at S1506 (P = 0);.;.;.;.;.;.;.;.;.;.;.;.;
MVP
MPC
2.3
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at